ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer

Ovarian cancer has the highest mortality rate among gynecological tumors. This is based on late diagnosis and the lack of early symptoms. To improve early detection, it is essential to find reliable biomarkers. The metalloprotease ADAM17 could be a potential marker, as it is highly expressed in many...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-11, Vol.13 (21), p.5563
Hauptverfasser:	Rogmans, Christoph, Kuhlmann, Jan Dominik, Hugendieck, Gerrit, Link, Theresa, Arnold, Norbert, Weimer, Jörg Paul, Flörkemeier, Inken, Rambow, Anna-Christina, Lieb, Wolfgang, Maass, Nicolai, Bauerschlag, Dirk O., Hedemann, Nina
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Ascites Ascitic fluid Biomarkers Breast cancer Cell culture Diagnosis Disease Enzyme-linked immunosorbent assay Epidermal growth factor Gynecology Lethality Metalloproteinase Ovarian cancer Patients Solid tumors Tumor cell lines Tumor cells Tumor markers Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!